Veronica Veschi

Pubblicazioni

Titolo Pubblicato in Anno
Neuroblastoma epigenetic landscape: drugging opportunities Neuroblastoma discoveries and challenges 2024
Protocol for generation and engineering of thyroid cell lineages using CRISPR-Cas9 editing to recapitulate thyroid cancer histotype progression STAR Protocol 2024
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells NATURE COMMUNICATIONS 2023
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment FRONTIERS IN MOLECULAR MEDICINE 2023
A single-cell transcriptomic analysis of Neuroblastomas revealed a selective cGAS-STING pathway suppression in malignant cells PROCEEDINGS IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE 2023
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy JOURNAL OF CLINICAL MEDICINE 2022
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy BIOMOLECULES 2022
Effective targeting of breast cancer stem cells by combined inhibition of Sam68 and Rad51 ONCOGENE 2022
Cancer cell targeting by CAR-T cells: A matter of stemness FRONTIERS IN MOLECULAR MEDICINE 2022
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells CANCERS 2022
Targeting epigenetic alterations in cancer stem cells FRONTIERS IN MOLECULAR MEDICINE 2022
Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy CANCERS 2021
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review GENES 2021
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment FRONTIERS IN ONCOLOGY 2021
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery NATURE COMMUNICATIONS 2021
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin ISCIENCE 2021
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells GUT 2021
Targeting MYCN in Pediatric and Adult Cancers FRONTIERS IN ONCOLOGY 2021
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant ONCOGENE 2020
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer CELL STEM CELL 2020

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma